Wednesday , February 21 2018
Home / boston

boston

Gingko Bioworks secures $275 million in Series D, valuing the company at over $1 billion

Boston biotech startup Gingko Bioworks has announced the raise of $275 million in Series D funding to build out its Bioworks3 production facility. The funding comes from previous investors Viking Global, Y Combinator’s Continuity Fund, Cascade Investment, Bill Gates, as well as new investor, General Atlantic. The company previously raised over …

Read More »

Where and why venture capitalists invest close to home

Jason Rowley is a venture capital and technology reporter for Crunchbase News. More posts by this contributor: Public market investors have the luxury of being able to make, invest and move their money anywhere they’d like. But the same isn’t true for startup investors, who, if conventional wisdom is to …

Read More »